Bioavailability of AZD0284 and IV Microtracer Study

NCT03029741 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis Vulgaris

Interventions

DRUG: AZD0284
DRUG: [14C]AZD0284

Sponsor

AstraZeneca